In silico evaluation of snake venom proteins against multidrug-resistant Mycobacterium tuberculosis: A molecular dynamics study and simulation dynamic

Background: Mycobacterium tuberculosis (Mtb), a pathogen that belongs to the M. tuberculosis complex (MTBC), causes tuberculosis (TB), an infectious bacterial disease. Although it usually affects the lungs and results in pulmonary tuberculosis, it can also lead to extra-pulmonary tuberculosis by af...

Full description

Saved in:
Bibliographic Details
Main Authors: Maged Fouda, Mohammad J. S. Mantargi, Mousa O. Germoush, Moustafa Sarhan, Modather F. Husein, Mohamed M. Abdel-Daim
Format: Article
Language:English
Published: Tripoli University 2025-02-01
Series:Open Veterinary Journal
Subjects:
Online Access:http://www.ejmanager.com/fulltextpdf.php?mno=227123
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850187635433144320
author Maged Fouda
Mohammad J. S. Mantargi
Mousa O. Germoush
Moustafa Sarhan
Modather F. Husein
Mohamed M. Abdel-Daim
author_facet Maged Fouda
Mohammad J. S. Mantargi
Mousa O. Germoush
Moustafa Sarhan
Modather F. Husein
Mohamed M. Abdel-Daim
author_sort Maged Fouda
collection DOAJ
description Background: Mycobacterium tuberculosis (Mtb), a pathogen that belongs to the M. tuberculosis complex (MTBC), causes tuberculosis (TB), an infectious bacterial disease. Although it usually affects the lungs and results in pulmonary tuberculosis, it can also lead to extra-pulmonary tuberculosis by affecting other regions of the body. TB, which ranks first on the list of infectious diseases that kill the most people, affects one-third of the world's population and has a high mortality and morbidity rate. The clinical treatment of active TB infection mainly relies on the use of isoniazid INH in combination with three other drugs—rifampin, pyrazinamide, and ethambutol. However, the situation is getting worse due to the rise of extremely drug-resistant tuberculosis (XDR-TB) and multidrug-resistant tuberculosis (MDR-TB). Finding more effective drugs is always a top priority. In this regard, animal venoms, such as snake toxins, contain antibacterial chemicals that have significant therapeutic properties and prevent bacterial infections and disease progression. This suggests that snake venom is a good natural source of promising novel anti-TB drugs. Aim: This study examines the snake venom protein's capacity in silico to interrupt the intracellular enzymes of M. tuberculosis, which is responsible for the development of MDR-TB in humans. Methods: From the protein RCSB-PDB, the active protein structure of catalase-peroxidase, RNA polymerase, and snake venom proteins was derived. Using molecular docking software such as PyRx, PyMOL, and Ligplot analyzers the interactions between those proteins and the targeted intracellular proteins were evaluated. Results: Our findings reveal fascinating affinities and interaction patterns between snake venom proteins and MDR-TB intracellular enzymes. Analysis of the effects of these interactions and their capacity to impair catalase-peroxidase and RNA polymerase showed that Russell's viper venom proteins were active against the catalase-peroxidase system, whereas Bothrops jararaca venom proteins were active against the RNA polymerase system. Conclusion: This study highlights a prospective approach for advancing anti-TB agents by using snake venom proteins to inhibit the growth, replication, and transmission of MDR-TB. This will provide a basis for exploring pharmacophore-based drugs to combat MDR-TB infections. [Open Vet J 2025; 15(2.000): 774-784]
format Article
id doaj-art-984671ffd9f441229909369e86b99ea2
institution OA Journals
issn 2226-4485
2218-6050
language English
publishDate 2025-02-01
publisher Tripoli University
record_format Article
series Open Veterinary Journal
spelling doaj-art-984671ffd9f441229909369e86b99ea22025-08-20T02:16:03ZengTripoli UniversityOpen Veterinary Journal2226-44852218-60502025-02-0115277478410.5455/OVJ.2025.v15.i2.26227123In silico evaluation of snake venom proteins against multidrug-resistant Mycobacterium tuberculosis: A molecular dynamics study and simulation dynamicMaged Fouda0Mohammad J. S. Mantargi1Mousa O. Germoush2Moustafa Sarhan3Modather F. Husein4Mohamed M. Abdel-Daim5jouf University Batterjee Medical College jouf University King Faisal University jouf University Batterjee Medical CollegeBackground: Mycobacterium tuberculosis (Mtb), a pathogen that belongs to the M. tuberculosis complex (MTBC), causes tuberculosis (TB), an infectious bacterial disease. Although it usually affects the lungs and results in pulmonary tuberculosis, it can also lead to extra-pulmonary tuberculosis by affecting other regions of the body. TB, which ranks first on the list of infectious diseases that kill the most people, affects one-third of the world's population and has a high mortality and morbidity rate. The clinical treatment of active TB infection mainly relies on the use of isoniazid INH in combination with three other drugs—rifampin, pyrazinamide, and ethambutol. However, the situation is getting worse due to the rise of extremely drug-resistant tuberculosis (XDR-TB) and multidrug-resistant tuberculosis (MDR-TB). Finding more effective drugs is always a top priority. In this regard, animal venoms, such as snake toxins, contain antibacterial chemicals that have significant therapeutic properties and prevent bacterial infections and disease progression. This suggests that snake venom is a good natural source of promising novel anti-TB drugs. Aim: This study examines the snake venom protein's capacity in silico to interrupt the intracellular enzymes of M. tuberculosis, which is responsible for the development of MDR-TB in humans. Methods: From the protein RCSB-PDB, the active protein structure of catalase-peroxidase, RNA polymerase, and snake venom proteins was derived. Using molecular docking software such as PyRx, PyMOL, and Ligplot analyzers the interactions between those proteins and the targeted intracellular proteins were evaluated. Results: Our findings reveal fascinating affinities and interaction patterns between snake venom proteins and MDR-TB intracellular enzymes. Analysis of the effects of these interactions and their capacity to impair catalase-peroxidase and RNA polymerase showed that Russell's viper venom proteins were active against the catalase-peroxidase system, whereas Bothrops jararaca venom proteins were active against the RNA polymerase system. Conclusion: This study highlights a prospective approach for advancing anti-TB agents by using snake venom proteins to inhibit the growth, replication, and transmission of MDR-TB. This will provide a basis for exploring pharmacophore-based drugs to combat MDR-TB infections. [Open Vet J 2025; 15(2.000): 774-784]http://www.ejmanager.com/fulltextpdf.php?mno=227123mdr-tbcatalase-peroxidaserna polymerasesnake toxinsmolecular docking
spellingShingle Maged Fouda
Mohammad J. S. Mantargi
Mousa O. Germoush
Moustafa Sarhan
Modather F. Husein
Mohamed M. Abdel-Daim
In silico evaluation of snake venom proteins against multidrug-resistant Mycobacterium tuberculosis: A molecular dynamics study and simulation dynamic
Open Veterinary Journal
mdr-tb
catalase-peroxidase
rna polymerase
snake toxins
molecular docking
title In silico evaluation of snake venom proteins against multidrug-resistant Mycobacterium tuberculosis: A molecular dynamics study and simulation dynamic
title_full In silico evaluation of snake venom proteins against multidrug-resistant Mycobacterium tuberculosis: A molecular dynamics study and simulation dynamic
title_fullStr In silico evaluation of snake venom proteins against multidrug-resistant Mycobacterium tuberculosis: A molecular dynamics study and simulation dynamic
title_full_unstemmed In silico evaluation of snake venom proteins against multidrug-resistant Mycobacterium tuberculosis: A molecular dynamics study and simulation dynamic
title_short In silico evaluation of snake venom proteins against multidrug-resistant Mycobacterium tuberculosis: A molecular dynamics study and simulation dynamic
title_sort in silico evaluation of snake venom proteins against multidrug resistant mycobacterium tuberculosis a molecular dynamics study and simulation dynamic
topic mdr-tb
catalase-peroxidase
rna polymerase
snake toxins
molecular docking
url http://www.ejmanager.com/fulltextpdf.php?mno=227123
work_keys_str_mv AT magedfouda insilicoevaluationofsnakevenomproteinsagainstmultidrugresistantmycobacteriumtuberculosisamoleculardynamicsstudyandsimulationdynamic
AT mohammadjsmantargi insilicoevaluationofsnakevenomproteinsagainstmultidrugresistantmycobacteriumtuberculosisamoleculardynamicsstudyandsimulationdynamic
AT mousaogermoush insilicoevaluationofsnakevenomproteinsagainstmultidrugresistantmycobacteriumtuberculosisamoleculardynamicsstudyandsimulationdynamic
AT moustafasarhan insilicoevaluationofsnakevenomproteinsagainstmultidrugresistantmycobacteriumtuberculosisamoleculardynamicsstudyandsimulationdynamic
AT modatherfhusein insilicoevaluationofsnakevenomproteinsagainstmultidrugresistantmycobacteriumtuberculosisamoleculardynamicsstudyandsimulationdynamic
AT mohamedmabdeldaim insilicoevaluationofsnakevenomproteinsagainstmultidrugresistantmycobacteriumtuberculosisamoleculardynamicsstudyandsimulationdynamic